Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SMITH, G. M.
Right arrow Articles by SCOTT, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SMITH, G. M.
Right arrow Articles by SCOTT, K. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 British Society for Rheumatology

research-article

MEASUREMENT OF HUMAN PHOSPHOLIPASE A IN ARTHRITIS PLASMA USING A NEWLY DEVELOPED SANDWICH ELISA

G. M. SMITH, R. L. WARD*, L. MCGUIGAN{dagger}, I. A. RAJKOVIC and K. F. SCOTT

Pacific Biotechnology Ltd 74 McLachlan Avenue, Rushcutters Bay, NSW 2011, Australia
*Department of Haematology, St Vincenis Hospital Victoria Street, Darlinghurst, NSW 2010, Australia
{dagger}Department of Rheumatology, St George Hospital Kogarah, NSW 2217, Australia

Correspondence to: Correspondence to G. Smith, Department of Haematology, St Vincents Hospital, Victoria Street, Darlinghurst, NSW 2010, Australia

A sandwich enzyme-linked immunosorbent assay (ELISA) for human non-pancreatic phospholipase A2 (PLA2) was developed using monoclonal antibodies raised against purified recombinant PLA2 This assay was shown to be specific for human non-pancreatic PLA2 showing no cross-reactivity with human pancreatic PLA2 or with snake venom PLA2 (Crotalus durissus). The immunoassay showed no cross-reactivity with plasma components, and was reproducible and quantitative between 39 pmol and 2·7 nmol PLA2/l The levels of non-pancreatic PLA2 in the plasma of patients with arthritis was measured using this immunoassay. There were significantly higher levels of PLA2 in patients with rheumatoid arthritis than in those with osteoarthritis or healthy controls. Plasma PLA2 was highest in those patients with active rheumatoid arthritis.

KEY WORDS: Human non-pancreatic phospholipase A2, Sandwich ELISA, Rheumatoid arthritis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
P. Sved, K. F. Scott, D. McLeod, N. J. C. King, J. Singh, T. Tsatralis, B. Nikolov, J. Boulas, L. Nallan, M. H. Gelb, et al.
Oncogenic Action of Secreted Phospholipase A2 in Prostate Cancer
Cancer Res., October 1, 2004; 64(19): 6934 - 6940.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Chandra, J. Jasti, P. Kaur, S. Dey, M. Perbandt, A. Srinivasan, Ch. Betzel, and T. P. Singh
Crystal Structure of a Complex Formed between a Snake Venom Phospholipase A2 and a Potent Peptide Inhibitor Phe-Leu-Ser-Tyr-Lys at 1.8 A Resolution
J. Biol. Chem., October 18, 2002; 277(43): 41079 - 41085.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. A. Styles, A. J. Aarsman, E. P. Vichinsky, and F. A. Kuypers
Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease
Blood, November 1, 2000; 96(9): 3276 - 3278.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Bidgood, O. S. Jamal, A. M. Cunningham, P. M. Brooks, and K. F. Scott
Type IIA Secretory Phospholipase A2 Up-Regulates Cyclooxygenase-2 and Amplifies Cytokine-Mediated Prostaglandin Production in Human Rheumatoid Synoviocytes
J. Immunol., September 1, 2000; 165(5): 2790 - 2797.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
O. S Jamal, P. G Conaghan, A. M Cunningham, P. M Brooks, V. F Munro, and K. F Scott
Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium
Ann Rheum Dis, September 1, 1998; 57(9): 550 - 558.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
J. Takasaki, Y. Kawauchi, and Y. Masuho
Synergistic Effect of Type II Phospholipase A2 and Platelet-Activating Factor on Mac-1 Surface Expression and Exocytosis of Gelatinase Granules in Human Neutrophils: Evidence for the 5-Lipoxygenase-Dependent Mechanism
J. Immunol., May 15, 1998; 160(10): 5066 - 5072.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Blom, A.T.J. Tool, P.C. Wever, G.J. Wolbink, M.C. Brouwer, J. Calafat, A. Egesten, E.F. Knol, C.E. Hack, D. Roos, et al.
Human Eosinophils Express, Relative to Other Circulating Leukocytes, Large Amounts of Secretory 14-kD Phospholipase A2
Blood, April 15, 1998; 91(8): 3037 - 3043.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Tseng, A. S. Inglis, and K. F. Scott
Native Peptide Inhibition. SPECIFIC INHIBITION OF TYPE II PHOSPHOLIPASES A2 BY SYNTHETIC PEPTIDES DERIVED FROM THE PRIMARY SEQUENCE
J. Biol. Chem., September 27, 1996; 271(39): 23992 - 23998.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. A. Boermeester, P. A. M. van Leeuwen, S. M. Coyle, G. J. Wolbink, C. E. Hack, and S. F. Lowry
Interleukin-1 Blockade Attenuates Mediator Release and Dysregulation of the Hemostatic Mechanism During Human Sepsis
Arch Surg, July 1, 1995; 130(7): 739 - 748.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
W. B. Church, A. S. Inglis, A. Tseng, R. Duell, P.-W. Lei, K. J. Bryant, and K. F. Scott
A Novel Approach to the Design of Inhibitors of Human Secreted Phospholipase A2 Based on Native Peptide Inhibition
J. Biol. Chem., August 24, 2001; 276(35): 33156 - 33164.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.